Form 603 Corporations Law Section 671B Notice of initial substantial holder To: Company Name/Scheme STARPHARMA HOLDINGS LIMITED ACN/ARSN 078 532 180 1. Details of substantial holder (1) Name: UBS Group AG and its related bodies corporate ACN/ARSN (if applicable) The holder became a...
Becoming a substantial holder
Filed with ASX ·
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- S&P DJI Announces September 2026 Quarterly Rebalance
- Ceasing to be a substantial holder
- FY26 Key Financial Results and Annual Report
- 2026 Appendix 4G and Corporate Governance Statement
- 2026 Annual Report
Later from Starpharma
- Annual General Meeting 2026 Date
- Chair and Deputy Chair Appointments
- Notification of cessation of securities - SPL
- Application for quotation of securities - SPL
- Change of Director's Interest Notice - C Maley
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma